Search Results - "Huso, D."

Refine Results
  1. 1

    Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis by Shriver, M, Stroka, K M, Vitolo, M I, Martin, S, Huso, D L, Konstantopoulos, K, Kontrogianni-Konstantopoulos, A

    Published in Oncogene (06-08-2015)
    “…Obscurins, encoded by the single OBSCN gene, are giant cytoskeletal proteins with structural and regulatory roles. The OBSCN gene is highly mutated in…”
    Get full text
    Journal Article
  2. 2

    Fluid shear promotes chondrosarcoma cell invasion by activating matrix metalloproteinase 12 via IGF-2 and VEGF signaling pathways by Wang, P, Chen, S-H, Hung, W-C, Paul, C, Zhu, F, Guan, P-P, Huso, D L, Kontrogianni-Konstantopoulos, A, Konstantopoulos, K

    Published in Oncogene (27-08-2015)
    “…Interstitial fluid flow in and around the tumor tissue is a physiologically relevant mechanical signal that regulates intracellular signaling pathways…”
    Get full text
    Journal Article
  3. 3

    PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis by Rybanska, I, Ishaq, O, Chou, J, Prakash, M, Bakhsheshian, J, Huso, D L, Franco, S

    Published in Oncogene (04-04-2013)
    “…Poly(ADP-ribose) polymerase 1 (PARP1) interacts genetically with the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) to suppress early-onset…”
    Get full text
    Journal Article
  4. 4

    Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture by Wang, Y., Huso, D.L., Harrington, J., Kellner, J., Jeong, D.K., Turney, J., McNiece, I.K.

    Published in Cytotherapy (Oxford, England) (2005)
    “…Human mesenchymal stem cells (hMSC) have been isolated and characterized extensively for a variety of clinical applications. Yet it is unclear how the…”
    Get full text
    Journal Article
  5. 5

    Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey by Park, J T, Johnson, N, Liu, S, Levesque, M, Wang, Y J, Ho, H, Huso, D, Maitra, A, Parsons, M J, Prescott, J D, Leach, S D

    Published in Oncogene (21-05-2015)
    “…Somatic activation of the KRAS proto-oncogene is evident in almost all pancreatic cancers, and appears to represent an initiating event. These mutations occur…”
    Get full text
    Journal Article
  6. 6

    An HIV-1 Transgenic Rat That Develops HIV-Related Pathology and Immunologic Dysfunction by Reid, W., Sadowska, M., Denaro, F., Rao, S., Foulke, J., Hayes, N., Jones, O., Doodnauth, D., Davis, H., Sill, A., O'Driscoll, P., Huso, D., Fouts, T., Lewis, G., Hill, M., Kamin-Lewis, R., Wei, C., Ray, P., Gallo, R. C., Reitz, M., Bryant, J.

    “…We report, to our knowledge, the first HIV type 1 (HIV-1) transgenic (Tg) rat. Expression of the transgene, consisting of an HIV-1 provirus with a functional…”
    Get full text
    Journal Article
  7. 7

    Loss of a single Hic1 allele accelerates polyp formation in ApcΔ716 mice by Mohammad, H P, Zhang, W, Prevas, H S, Leadem, B R, Zhang, M, Herman, J G, Hooker, C M, Watkins, D N, Karim, B, Huso, D L, Baylin, S B

    Published in Oncogene (09-06-2011)
    “…Adenomatous polyposis coli ( APC) gene mutations have been implicated in familial and sporadic gastrointestinal (GI) cancers. APC mutations are associated with…”
    Get full text
    Journal Article
  8. 8

    Mutant PIK3CA promotes cell growth and invasion of human cancer cells by Samuels, Yardena, Diaz, Luis A., Schmidt-Kittler, Oleg, Cummins, Jordan M., DeLong, Laura, Cheong, Ian, Rago, Carlo, Huso, David L., Lengauer, Christoph, Kinzler, Kenneth W., Vogelstein, Bert, Velculescu, Victor E.

    Published in Cancer cell (01-06-2005)
    “…PIK3CA is mutated in diverse human cancers, but the functional effects of these mutations have not been defined. To evaluate the consequences of PIK3CA…”
    Get full text
    Journal Article
  9. 9

    SU‐E‐T‐324: A Nephron‐Based Dosimetry Model for Alpha‐Particle Radiopharmaceutical Therapy by Hobbs, R, Song, H, Huso, D, Sgouros, G

    Published in Medical Physics (01-06-2011)
    “…Purpose: We describe a nephron‐based dosimetry model for renal toxicity for alpha‐particle radipharmaceutical therapy suited to the short range and high linear…”
    Get full text
    Conference Proceeding Journal Article
  10. 10

    Loss of a single Hic1 allele accelerates polyp formation in Apc(Δ716) mice by Mohammad, H P, Zhang, W, Prevas, H S, Leadem, B R, Zhang, M, Herman, J G, Hooker, C M, Watkins, D N, Karim, B, Huso, D L, Baylin, S B

    Published in Oncogene (09-06-2011)
    “…Adenomatous polyposis coli (APC) gene mutations have been implicated in familial and sporadic gastrointestinal (GI) cancers. APC mutations are associated with…”
    Get full text
    Journal Article
  11. 11

    Combination Bacteriolytic Therapy for the Treatment of Experimental Tumors by Dang, Long H., Bettegowda, Chetan, Huso, David L., Kinzler, Kenneth W., Vogelstein, Bert

    “…Current chemotherapeutic approaches for cancer are in part limited by the inability of drugs to destroy neoplastic cells within poorly vascularized…”
    Get full text
    Journal Article
  12. 12

    Targeting Vascular and Avascular Compartments of Tumors with C. novyi-NT and Anti-microtubule Agents by Dang, L.H., Bettegowda, C., Agrawal, N., Cheong, I., Huso, D., Frost, P., Loganzo, F., Greenberger, L., Barkoczy, J., Pettit, G.R., Smith, A.B., Gurulingappa, H., Khan, S., Parmigiani, G., Kinzler, K.W., Zhou, S., Vogelstein, B.

    Published in Cancer biology & therapy (01-03-2004)
    “…Current approaches for treating cancer are limited, in part, by the inability of drugs to affect the poorly vascularized regions of tumors. We have found that…”
    Get full text
    Journal Article
  13. 13
  14. 14

    In vivo mammary tumourigenesis in the Sprague-Dawley rat and microdosimetric correlates by Dicello, J F, Christian, A, Cucinotta, F A, Gridley, D S, Kathirithamby, R, Mann, J, Markham, A R, Moyers, M F, Novak, G R, Piantadosi, S, Ricart-Arbona, R, Simonson, D M, Strandberg, J D, Vazquez, M, Williams, J R, Zhang, Y, Zhou, H, Huso, D

    Published in Physics in medicine & biology (21-08-2004)
    “…Standard methods for risk assessments resulting from human exposures to mixed radiation fields in Space consisting of different particle types and energies…”
    Get more information
    Journal Article
  15. 15

    Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG by Sun, Lin-Quan, Lee, David W, Zhang, Quangeng, Xiao, Weihong, Raabe, Eric H, Meeker, Alan, Miao, Dengshun, Huso, David L, Arceci, Robert J

    Published in Genes & development (01-05-2004)
    “…Imperfect maintenance of genome integrity has been postulated to be an important cause of aging. Here we provide support for this hypothesis by demonstrating…”
    Get full text
    Journal Article
  16. 16

    Specific Ablation of Stat3β Distorts the Pattern of Stat3-Responsive Gene Expression and Impairs Recovery from Endotoxic Shock by Yoo, Joo-Yeon, Huso, David L., Nathans, Daniel, Desiderio, Stephen

    Published in Cell (08-02-2002)
    “…Alternative splicing of the gene for Stat3, a transcription factor activated by the IL-6 family of cytokines, produces two isoforms: Stat3α and a…”
    Get full text
    Journal Article
  17. 17

    Nitric Oxide Synthase in Cardiac Sarcoplasmic Reticulum by Xu, Kai Y., Huso, David L., Dawson, Ted M., Bredt, David S., Becker, Lewis C.

    “…NO·is a free radical that modulates heart function and metabolism. We report that a neuronal-type NO synthase (NOS) is located on cardiac sarcoplasmic…”
    Get full text
    Journal Article
  18. 18

    The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia by YI XU, SUMTER, Takita Felder, BHATTACHARYA, Raka, TESFAYE, Abeba, FUCHS, Ephraim J, WOOD, Lisa J, HUSO, David L, RESAR, Linda M. S

    Published in Cancer research (Chicago, Ill.) (15-05-2004)
    “…HMG-I/Y is overexpressed in human cancer, although a direct role for this gene in transformation has not been established. We generated transgenic mice with…”
    Get full text
    Journal Article
  19. 19

    Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease by BALDWIN, B. R, LI, L, TSE, K.-F, SMALL, S, COLLECTOR, M, WHARTENBY, K. A, SHARKIS, S. J, RACKE, F, HUSO, D, SMALL, D

    Published in Leukemia (01-04-2007)
    “…Evidence is continuing to accumulate that the FMS-like tyrosine kinase 3 (FLT3) receptor plays an important role in acute leukemias. Acute myeloid leukemia…”
    Get full text
    Journal Article
  20. 20

    Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis by LING QI, STRONG, Margaret A, KARIM, Baktiar O, ARMANIOS, Mary, HUSO, David L, GREIDER, Carol W

    Published in Cancer research (Chicago, Ill.) (01-12-2003)
    “…To examine the role of ataxia-telangiectasia mutated (Atm) in telomere function, we generated Atm and telomerase null mice (Atm(-/-) mTR(-/-) iG6 mice). These…”
    Get full text
    Journal Article